Contribution of Nanotechnologies to Vaccine Development and Drug Delivery against Respiratory Viruses

According to the Center for Disease Control and Prevention (CDC), the coronavirus disease 2019, a respiratory viral illness linked to significant morbidity, mortality, production loss, and severe economic depression, was the third-largest cause of death in 2020. Respiratory viruses such as influenza...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Mahdi Ftouh, Nesrine Kalboussi, Nabil Abid, Souad Sfar, Nathalie Mignet, Badr Bahloul
Formato:	article
Lenguaje:	EN
Publicado:	Hindawi Limited 2021
Materias:	Biology (General) QH301-705.5
Acceso en línea:	https://doaj.org/article/18de53fd7fc94969a3149e1c5c1668a2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:18de53fd7fc94969a3149e1c5c1668a2
record_format	dspace
spelling	oai:doaj.org-article:18de53fd7fc94969a3149e1c5c1668a22021-11-08T02:37:06ZContribution of Nanotechnologies to Vaccine Development and Drug Delivery against Respiratory Viruses1687-476510.1155/2021/6741290https://doaj.org/article/18de53fd7fc94969a3149e1c5c1668a22021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/6741290https://doaj.org/toc/1687-4765According to the Center for Disease Control and Prevention (CDC), the coronavirus disease 2019, a respiratory viral illness linked to significant morbidity, mortality, production loss, and severe economic depression, was the third-largest cause of death in 2020. Respiratory viruses such as influenza, respiratory syncytial virus, SARS-CoV-2, and adenovirus, are among the most common causes of respiratory illness in humans, spreading as pandemics or epidemics throughout all continents. Nanotechnologies are particles in the nanometer range made from various compositions. They can be lipid-based, polymer-based, protein-based, or inorganic in nature, but they are all bioinspired and virus-like. In this review, we aimed to present a short review of the different nanoparticles currently studied, in particular those which led to publications in the field of respiratory viruses. We evaluated those which could be beneficial for respiratory disease-based viruses; those which already have contributed, such as lipid nanoparticles in the context of COVID-19; and those which will contribute in the future either as vaccines or antiviral drug delivery systems. We present a short assessment based on a critical selection of evidence indicating nanotechnology’s promise in the prevention and treatment of respiratory infections.Mahdi FtouhNesrine KalboussiNabil AbidSouad SfarNathalie MignetBadr BahloulHindawi LimitedarticleBiology (General)QH301-705.5ENPPAR Research, Vol 2021 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Biology (General) QH301-705.5
spellingShingle	Biology (General) QH301-705.5 Mahdi Ftouh Nesrine Kalboussi Nabil Abid Souad Sfar Nathalie Mignet Badr Bahloul Contribution of Nanotechnologies to Vaccine Development and Drug Delivery against Respiratory Viruses
description	According to the Center for Disease Control and Prevention (CDC), the coronavirus disease 2019, a respiratory viral illness linked to significant morbidity, mortality, production loss, and severe economic depression, was the third-largest cause of death in 2020. Respiratory viruses such as influenza, respiratory syncytial virus, SARS-CoV-2, and adenovirus, are among the most common causes of respiratory illness in humans, spreading as pandemics or epidemics throughout all continents. Nanotechnologies are particles in the nanometer range made from various compositions. They can be lipid-based, polymer-based, protein-based, or inorganic in nature, but they are all bioinspired and virus-like. In this review, we aimed to present a short review of the different nanoparticles currently studied, in particular those which led to publications in the field of respiratory viruses. We evaluated those which could be beneficial for respiratory disease-based viruses; those which already have contributed, such as lipid nanoparticles in the context of COVID-19; and those which will contribute in the future either as vaccines or antiviral drug delivery systems. We present a short assessment based on a critical selection of evidence indicating nanotechnology’s promise in the prevention and treatment of respiratory infections.
format	article
author	Mahdi Ftouh Nesrine Kalboussi Nabil Abid Souad Sfar Nathalie Mignet Badr Bahloul
author_facet	Mahdi Ftouh Nesrine Kalboussi Nabil Abid Souad Sfar Nathalie Mignet Badr Bahloul
author_sort	Mahdi Ftouh
title	Contribution of Nanotechnologies to Vaccine Development and Drug Delivery against Respiratory Viruses
title_short	Contribution of Nanotechnologies to Vaccine Development and Drug Delivery against Respiratory Viruses
title_full	Contribution of Nanotechnologies to Vaccine Development and Drug Delivery against Respiratory Viruses
title_fullStr	Contribution of Nanotechnologies to Vaccine Development and Drug Delivery against Respiratory Viruses
title_full_unstemmed	Contribution of Nanotechnologies to Vaccine Development and Drug Delivery against Respiratory Viruses
title_sort	contribution of nanotechnologies to vaccine development and drug delivery against respiratory viruses
publisher	Hindawi Limited
publishDate	2021
url	https://doaj.org/article/18de53fd7fc94969a3149e1c5c1668a2
work_keys_str_mv	AT mahdiftouh contributionofnanotechnologiestovaccinedevelopmentanddrugdeliveryagainstrespiratoryviruses AT nesrinekalboussi contributionofnanotechnologiestovaccinedevelopmentanddrugdeliveryagainstrespiratoryviruses AT nabilabid contributionofnanotechnologiestovaccinedevelopmentanddrugdeliveryagainstrespiratoryviruses AT souadsfar contributionofnanotechnologiestovaccinedevelopmentanddrugdeliveryagainstrespiratoryviruses AT nathaliemignet contributionofnanotechnologiestovaccinedevelopmentanddrugdeliveryagainstrespiratoryviruses AT badrbahloul contributionofnanotechnologiestovaccinedevelopmentanddrugdeliveryagainstrespiratoryviruses
_version_	1718442977339113472

Contribution of Nanotechnologies to Vaccine Development and Drug Delivery against Respiratory Viruses

Ejemplares similares